typ : |
Czasopismo |
|
Zespoły badawcze : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
Autorzy : |
Ensom MHH, Decarie D, Sheppard I. |
Tytuł : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
Numer : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
Poziom wiarygodności : |
|
stabilność fizyczną : |
|
Stabilność chemiczna : |
|
Inne metody : |
|
Komentarze : |
|
Listy
Lansoprazole
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
|
25°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
25°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
|
4°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
4°C |
|
91 |
|
|
|
|
|